Meningococcal polysaccharide capsule antigens — Drug Target

All drugs that target Meningococcal polysaccharide capsule antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Meningococcal conjugate vaccine

Phase 3 pipeline (1)

• Meningococcal conjugate vaccine GSK134612 · GlaxoSmithKline · Meningococcal conjugate vaccine · Immunology / Infectious Disease
  This conjugate vaccine stimulates the immune system to produce antibodies against meningococcal polysaccharide capsules by linking them to a protein carrier.